After going after the companies making compounded versions of their drugs, GLP-1 makers are now going into business with the online telehealth sites that were previously selling the copycats.

AI is a transformational force in healthcare, but without cybersecurity as its foundation, it becomes a high-stakes gamble.

Massachusetts faced some of the heaviest losses nationally, with cuts affecting more than $100 million in NIH grants.

Health and Human Services employees were told in March to remove nicknames from email systems and signatures to comply with ...

British animal genetics company Genus on Wednesday said the U.S. Food and Drug Administration (FDA) approved its PRP gene edit under its PRRS Resistant Pig ("PRP") programme for use in the U.S. food ...

More than 20,000 jobs were eliminated, billions of dollars in scientific research has been threatened or paused, and a budget ...

In recent weeks, top health officials have floated an idea for bringing down prescription drug costs in the United States: ...

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

Heeding the call to ban artificial ingredients by Health and Human Services Secretary Robert F. Kennedy Jr., PepsiCo isn’t ...

Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients ...

Color is powerful driver of consumer behavior and changes can backfire, Giusti noted. In 2016, food giant General Mills ...

On April 22, the Department of Health and Human Services and the Food and Drug Administration announced measures designed to ...